CRITICAL CLINICAL DISCLAIMER
This calculator implements 2020 ASHP/IDSA/SIDP vancomycin monitoring guidelines for AUC-based dosing. Results are estimates only and must be validated by a licensed pharmacist or physician. Individual patient factors including renal function trends, concurrent nephrotoxins, and infection severity must be considered. Vancomycin dosing errors can cause treatment failure or serious nephrotoxicity.
2020 Guideline Update
The 2020 ASHP/IDSA/SIDP guidelines recommend AUC/MIC monitoring (target AUC 400-600 mg·h/L for MIC ≤1) over trough-only monitoring to optimize efficacy while reducing nephrotoxicity risk. Bayesian software or first-order pharmacokinetic calculations are recommended.
For initial dosing based on patient characteristics
Target AUC/MIC 400-600 for MIC ≤1 mg/L
Embed This Calculator on Your Website
Add this free calculator to your blog, website, or CMS with a simple copy-paste embed code.
Introduction
Vancomycin has been the primary treatment for serious MRSA infections for decades, but its therapeutic window is narrow enough that both underdosing and overdosing carry serious consequences. Underdosing leads to treatment failure in bacteremia and endocarditis. Overdosing causes nephrotoxicity, the most common drug-induced cause of acute kidney injury in hospitalized patients. In 2020, the American Society of Health-System Pharmacists (ASHP), the Infectious Diseases Society of America (IDSA), and the Society of Infectious Diseases Pharmacists (SIDP) issued a landmark joint guideline replacing trough-only monitoring with AUC/MIC-guided dosing as the new standard of care. The guideline established a target AUC of 400 to 600 mg·h/L for most MRSA infections, with observational data showing that AUC-guided dosing reduces nephrotoxicity by 30% to 40% compared to trough-only targeting. This calculator implements Bayesian AUC estimation using two-level serum concentration sampling.
What This Calculator Does
This calculator estimates vancomycin AUC (area under the concentration-time curve) using two serum vancomycin levels (peak and trough, or two post-dose levels), dosing interval, and patient renal function expressed as CrCl. It implements the two-compartment linear pharmacokinetic model recommended in the 2020 ASHP/IDSA/SIDP guideline to compute estimated AUC/24h, the AUC/MIC ratio given a user-specified MIC, and a dose adjustment recommendation to achieve the target AUC of 400 to 600 mg·h/L. It is intended for use by clinical pharmacists and pharmacy students in monitored inpatient settings.
The Formula
Vancomycin pharmacokinetics follow a two-compartment model. Clearance (CL) is primarily renal and is estimated from creatinine clearance using population-based pharmacokinetic parameters. Volume of distribution (Vd) is approximately 0.7 L/kg in patients without fluid overload. The elimination rate constant (ke) = CL / Vd. Using two observed serum concentrations drawn at known times post-dose, the calculator solves for patient-specific ke and Vd using the log-linear decline between levels. AUC per dosing interval is then calculated as Dose / CL. AUC/24h normalizes this to a 24-hour period regardless of the dosing frequency used.
Step-by-Step Example
Collect serum vancomycin levels with precise timing
Level 1 (peak): drawn 1 to 2 hours after the end of a 1-hour infusion. Example: 28.4 mg/L drawn 1.5 hours post-infusion end. Level 2 (trough): drawn within 30 minutes before the next dose. Example: 12.1 mg/L. Dose given: 1,500 mg over 1 hour every 12 hours. Level timing must be confirmed from nursing documentation, not patient recall.
Enter patient CrCl and weight
Patient: 58-year-old male, 82 kg, SCr 0.9 mg/dL. CrCl (Cockcroft-Gault) = [(140 - 58) × 82] / [72 × 0.9] = 104 mL/min. Weight used: 82 kg (within 30% of IBW). Estimated vancomycin CL = 0.00083 × 104 × 60 + 0.0044 × 82 = 5.18 + 0.36 = 5.54 L/h.
Calculate patient-specific AUC/24h
Using the two observed levels (28.4 and 12.1 mg/L) at known post-dose times, solve for patient-specific ke and Vd. Estimated ke from two-level method: 0.0833 h-1. Patient Vd = Dose / [(Peak) × (1 - e^(-ke×tinf)) / (ke × tinf)] = approximately 66.5 L. AUC per dose = Dose / CL = 1,500 mg / 5.54 L/h = 270.8 mg·h/L. AUC/24h = 270.8 × (24/12) = 541.6 mg·h/L.
Assess target attainment and adjust dose if needed
Target AUC/24h: 400 to 600 mg·h/L. Calculated AUC/24h: 541.6 mg·h/L. Target achieved. Continue current regimen with repeat levels after 48 hours or with any change in renal function. If AUC was below 400 mg·h/L, increase dose proportionally: new dose = current dose × (target AUC midpoint / calculated AUC) = 1,500 × (500/541.6) = 1,385 mg, rounded to 1,250 mg or 1,500 mg based on available vial sizes and clinical judgment.
Real-World Use Cases
Initial AUC-Based Dosing for MRSA Bacteremia
A clinical pharmacist receives a new vancomycin order for a 71-year-old female with MRSA bloodstream infection. CrCl is 38 mL/min. Using population PK parameters and AUC-guided dosing, the calculator recommends 750 mg every 12 hours as a starting regimen, with first levels drawn after the third dose. Traditional trough-only dosing in this patient would target a trough of 15 to 20 mg/L, which pharmacokinetic modeling shows correlates with an AUC exceeding 700 mg·h/L in renally-impaired patients, placing the patient in the nephrotoxicity risk zone.
Dose Adjustment After Renal Function Change
A patient previously stable on 1,000 mg every 12 hours develops AKI. SCr rises from 0.8 to 2.4 mg/dL over 36 hours. New CrCl: 22 mL/min (previously 85 mL/min). The calculator projects that without dose adjustment, estimated AUC/24h will increase from 430 to approximately 1,100 mg·h/L as elimination slows. The immediate recommendation: hold vancomycin, recheck levels in 24 hours, and recalculate pharmacokinetics when creatinine stabilizes.
Comparing AUC Target Attainment for Different MICs
A pharmacy student uses the calculator to understand why MRSA MIC matters in AUC-guided dosing. For an MIC of 1.0 mg/L, an AUC/24h of 500 mg·h/L gives an AUC/MIC ratio of 500, well above the pharmacodynamic target of 400. For an MRSA isolate with MIC of 2.0 mg/L (the upper end of susceptibility), AUC/MIC = 250, below the efficacy threshold. This illustrates why vancomycin is often inadequate for high-MIC MRSA strains and why alternative agents should be considered.
Comparison
| AUC/24h (mg·h/L) | Clinical Interpretation | Action Required |
|---|---|---|
| Below 200 | Significantly subtherapeutic | Immediate dose increase; check for drug interactions |
| 200-399 | Subtherapeutic | Dose increase needed; confirm level timing accuracy |
| 400-600 | Target range (ASHP/IDSA 2020 guideline) | Continue; monitor renal function and levels every 48-72h |
| 601-800 | Supratherapeutic | Consider dose reduction; assess nephrotoxicity risk |
| Above 800 | Significantly supratherapeutic | Dose reduction or extended interval; nephrology consult if AKI |
Common Mistakes to Avoid
Drawing levels at incorrect times relative to the dose. The two-level AUC method is highly sensitive to sampling time accuracy. A trough drawn 2 hours before the next dose instead of 30 minutes before will produce a significantly lower concentration value, leading to underestimation of AUC and potential dose increases that push the patient supratherapeutic. Always confirm draw times from the electronic medication administration record, not from the lab specimen time stamp.
Using a serum creatinine value from before clinical stabilization. Population pharmacokinetic estimates of vancomycin clearance require a steady-state creatinine reflecting current renal function. Using admission creatinine in a post-resuscitation patient who is diuresing aggressively will underestimate renal clearance and produce an overly conservative dose estimate.
Applying the 2020 AUC guideline target to non-MRSA infections without adjustment. The AUC/24h target of 400 to 600 mg·h/L was derived for serious MRSA infections where the typical MIC is 0.5 to 1.0 mg/L. For infections caused by organisms with lower MICs (e.g., MSSA, streptococcal infections treatable with vancomycin), lower AUC targets may be clinically appropriate and carry less nephrotoxicity risk.
Failing to account for vancomycin pharmacokinetics in critically ill patients with augmented renal clearance (ARC). Patients under 55 with sepsis or trauma often have CrCl above 130 mL/min (ARC). Standard dosing in these patients produces subtherapeutic AUC. The calculator will recommend higher doses or shorter intervals, which may surprise clinicians accustomed to standard dosing nomograms.
Frequently Asked Questions
Accuracy and Disclaimer
This calculator implements pharmacokinetic principles consistent with the 2020 ASHP/IDSA/SIDP Consensus Guidelines for vancomycin dosing and monitoring. Results are intended to assist clinical pharmacists and qualified healthcare professionals in pharmacokinetic calculations and are not a substitute for clinical judgment, individualized patient assessment, or formal therapeutic drug monitoring programs. Vancomycin dosing decisions must account for infection severity, source control, microbiology results, and renal function trajectory. This tool is not intended for use by patients or non-clinical personnel. Consult your institution's clinical pharmacy department or pharmacokinetics service for patient-specific dosing recommendations.
Conclusion
AUC-guided vancomycin monitoring requires accurate serum level timing, reliable MIC data, and pharmacokinetic interpretation by a clinical pharmacist. The AUC calculation here is a starting point for individualized dosing decisions, not a final answer. Before calculating AUC, ensure your patient's renal function is current by running the Creatinine Clearance Calculator using the most recent stable serum creatinine. For patients on multiple renally-cleared antimicrobials, cross-reference potential additive nephrotoxicity with the Drug Interaction Severity Reference.
Related Pharmacy & Clinical Pharmacology Calculators
Creatinine Clearance (Cockcroft-Gault) Calculator
Calculate creatinine clearance for renal function assessment and drug dosing adjustment in patients with renal impairment using the Cockcroft-Gault equation with optional IBW/ABW adjustment for obese patients.
Use CalculatorPharmacy & Clinical PharmacologyPharmacy Compounding Cost Calculator
Calculate accurate compounding prices including ingredient costs, pharmacist/technician labor, overhead allocation, supplies, profit margin, and dispensing fees for custom pharmaceutical preparations.
Use CalculatorPharmacy & Clinical PharmacologyDrug Interaction Severity Reference
Lexi-Interact severity classification reference (Risk Ratings A through X) with common high-risk drug interactions, clinical significance, and management recommendations for pharmacy practice.
Use CalculatorPharmacy & Clinical PharmacologyMedication Adherence Rate Calculator
Calculate medication adherence using PDC (Proportion of Days Covered), MPR, or pill count methods with CMS Star Rating threshold analysis and MTM intervention recommendations.
Use CalculatorYou May Also Find Useful
Tax Calculator
Estimate your 2026 federal income tax based on filing status, gross income, deductions, and current tax brackets. See your marginal and effective tax rates instantly.
Use CalculatorFinance & AccountingSalary to Hourly Calculator
Convert your annual salary to an hourly wage instantly. Adjust for hours per week, weeks per year, and overtime to find your true hourly rate.
Use CalculatorFinance & AccountingCommission Calculator
Determine sales commissions based on revenue, rate tiers, and bonus structures.
Use Calculator